What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Endocrinology
- Cancer
His main research concerns Internal medicine, Endocrinology, Acromegaly, Cushing syndrome and Cabergoline.
His studies examine the connections between Internal medicine and genetics, as well as such issues in Diabetes mellitus, with regards to Disease.
His study in Endocrinology is interdisciplinary in nature, drawing from both Prospective cohort study and Vascular disease.
Rosario Pivonello has included themes like Cardiomyopathy, Octreotide, Retrospective cohort study and Epidemiology in his Acromegaly study.
His Cushing syndrome research incorporates elements of S syndrome, Cortisol secretion, Metabolic syndrome and Bone mineral.
His Cabergoline research integrates issues from Bromocriptine, Microprolactinoma, Prolactinoma and Dopamine agonist.
His most cited work include:
- Persistence of increased cardiovascular risk in patients with Cushing's disease after five years of successful cure. (351 citations)
- Cardiovascular risk factors and common carotid artery caliber and stiffness in patients with Cushing's disease during active disease and 1 year after disease remission. (257 citations)
- The Medical Treatment of Cushing’s Disease: Effectiveness of Chronic Treatment with the Dopamine Agonist Cabergoline in Patients Unsuccessfully Treated by Surgery (244 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Internal medicine, Endocrinology, Acromegaly, Cushing's disease and Somatostatin.
His Internal medicine research includes themes of Gastroenterology and Diabetes mellitus.
Rosario Pivonello combines subjects such as Surgery, Cardiomyopathy, Pharmacotherapy and Disease with his study of Acromegaly.
His Cushing's disease study which covers Pasireotide that intersects with Oncology.
His studies in Somatostatin integrate themes in fields like Hormone and Peptide hormone.
Rosario Pivonello works mostly in the field of Cabergoline, limiting it down to concerns involving Dopamine agonist and, occasionally, Dopamine receptor.
He most often published in these fields:
- Internal medicine (79.72%)
- Endocrinology (62.50%)
- Acromegaly (26.67%)
What were the highlights of his more recent work (between 2018-2021)?
- Internal medicine (79.72%)
- Endocrinology (62.50%)
- Cushing's disease (14.44%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Internal medicine, Endocrinology, Cushing's disease, Gastroenterology and Diabetes mellitus.
Adverse effect, Acromegaly, Pituitary adenoma, Disease and S syndrome are subfields of Internal medicine in which his conducts study.
Rosario Pivonello combines Endocrinology and Context in his research.
His Cushing's disease study incorporates themes from Clinical trial, Phases of clinical research, hirsutism, Pasireotide and Nausea.
As part of the same scientific family, Rosario Pivonello usually focuses on Gastroenterology, concentrating on Transsphenoidal surgery and intersecting with Hypokalemia, Inferior petrosal sinus sampling, Cushing syndrome, Etiology and Tertiary care.
His Diabetes mellitus study combines topics from a wide range of disciplines, such as Meta-analysis, Urinary system, Respiratory rate and Confounding.
Between 2018 and 2021, his most popular works were:
- Advances in the medical treatment of Cushing's syndrome (33 citations)
- Metabolic Disorders and Male Hypogonadotropic Hypogonadism. (24 citations)
- Efficacy and safety of levoketoconazole in the treatment of endogenous Cushing's syndrome (SONICS): a phase 3, multicentre, open-label, single-arm trial (22 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Gene
Rosario Pivonello mainly focuses on Internal medicine, Adrenal insufficiency, Randomized controlled trial, Adverse effect and Cushing's disease.
In most of his Internal medicine studies, his work intersects topics such as Endocrinology.
His research in Adrenal insufficiency intersects with topics in Observational study, Outpatient clinic, Prednisone and Dosing.
His studies deal with areas such as Medical literature and Intensive care medicine as well as Randomized controlled trial.
The concepts of his Adverse effect study are interwoven with issues in Lipid profile, Urinary system, QT interval and Discontinuation.
His Cushing's disease research is multidisciplinary, incorporating perspectives in Diabetes mellitus, Body mass index, Clinical trial and Gastroenterology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
